Sonnet BioTherapeutics Implements Reverse Stock Split : vima

Sonnet BioTherapeutics Holdings Inc. (SONN) will implement a 1-for-22 reverse stock split of its outstanding common stock at the commencement of trading today. In premarket trading today, the stock is up over 2,300% at $4.

Related Keywords

, Sonnet Biotherapeutics Holdings Inc , Nasdaq Capital , Safety Monitoring Board , Nasdaq , Reverse Stock Split , Neuropathy , Bonn ,